AGN-199201 for the Treatment of Erythema With Rosacea

Summary

This study will evaluate the safety and efficacy of 3 doses of AGN-199201 once and twice daily compared to vehicle for the treatment of moderate to severe facial erythema associated with rosacea.

Timeline

Start

2012-12

Primary completion

2013-05

Completion

2013-06

Drugs

Indications